Significance of serum concentrations of E-selectin and CA19-9 in the prognosis of colorectal cancer

Harunobu Sato, Nobuteru Usuda, Makoto Kuroda, Shuji Hashimoto, Morito Maruta, Koutarou Maeda

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objective: Interaction of CA19-9 with E-selectin is involved in initiation of hematogenous metastases. We investigated whether serum concentrations of E-selectin and CA19-9 are good predictors of hematogenous metastases and prognosis in colorectal cancer. Methods: Pre-operative serum samples were obtained from 152 patients with colorectal cancer, and from 28 healthy volunteers. Correlation between serum E-selectin and CA19-9 was studied in terms of clinically detected hematogenous metastases and prognosis of patients. Results: Low serum concentration of E-selectin was defined as <50 U/ml in healthy volunteers, and on that basis, 20.4% of all patients belonged to the high E-selectin group. Several distinctive characteristics were observed in the clinical course of patients with high serum concentrations of both CA19-9 and E-selectin. The rate of Dukes' D cancer was significantly higher, and curative surgery was performed less frequently in patients with high serum concentrations of both CA19-9 and E-selectin (60 and 40%) than in others. However, there was no significant difference in the frequency of recurrence after curative surgery between patients with high serum concentrations of both CA19-9 and E-selectin (25.0%) and others. Overall the 5-year survival rate was significantly lower in patients with high serum concentrations of both CA19-9 and E-selectin (34.3%) than in other patients. Even if the serum concentration of CA19-9 was high, prognosis was not poor in patients with low serum concentration of E-selectin. Conclusions: These results suggested that it was useful to measure both CA19-9 and E-selectin as markers of hematogenous metastases and as predictors of prognosis in colorectal cancer.

Original languageEnglish
Article numberhyq095
Pages (from-to)1073-1080
Number of pages8
JournalJapanese Journal of Clinical Oncology
Volume40
Issue number11
DOIs
Publication statusPublished - 01-11-2010

Fingerprint

E-Selectin
Colorectal Neoplasms
Serum
Neoplasm Metastasis
Healthy Volunteers
Survival Rate

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Sato, Harunobu ; Usuda, Nobuteru ; Kuroda, Makoto ; Hashimoto, Shuji ; Maruta, Morito ; Maeda, Koutarou. / Significance of serum concentrations of E-selectin and CA19-9 in the prognosis of colorectal cancer. In: Japanese Journal of Clinical Oncology. 2010 ; Vol. 40, No. 11. pp. 1073-1080.
@article{0c18f229c9ba41a390ffabbabd97d9bd,
title = "Significance of serum concentrations of E-selectin and CA19-9 in the prognosis of colorectal cancer",
abstract = "Objective: Interaction of CA19-9 with E-selectin is involved in initiation of hematogenous metastases. We investigated whether serum concentrations of E-selectin and CA19-9 are good predictors of hematogenous metastases and prognosis in colorectal cancer. Methods: Pre-operative serum samples were obtained from 152 patients with colorectal cancer, and from 28 healthy volunteers. Correlation between serum E-selectin and CA19-9 was studied in terms of clinically detected hematogenous metastases and prognosis of patients. Results: Low serum concentration of E-selectin was defined as <50 U/ml in healthy volunteers, and on that basis, 20.4{\%} of all patients belonged to the high E-selectin group. Several distinctive characteristics were observed in the clinical course of patients with high serum concentrations of both CA19-9 and E-selectin. The rate of Dukes' D cancer was significantly higher, and curative surgery was performed less frequently in patients with high serum concentrations of both CA19-9 and E-selectin (60 and 40{\%}) than in others. However, there was no significant difference in the frequency of recurrence after curative surgery between patients with high serum concentrations of both CA19-9 and E-selectin (25.0{\%}) and others. Overall the 5-year survival rate was significantly lower in patients with high serum concentrations of both CA19-9 and E-selectin (34.3{\%}) than in other patients. Even if the serum concentration of CA19-9 was high, prognosis was not poor in patients with low serum concentration of E-selectin. Conclusions: These results suggested that it was useful to measure both CA19-9 and E-selectin as markers of hematogenous metastases and as predictors of prognosis in colorectal cancer.",
author = "Harunobu Sato and Nobuteru Usuda and Makoto Kuroda and Shuji Hashimoto and Morito Maruta and Koutarou Maeda",
year = "2010",
month = "11",
day = "1",
doi = "10.1093/jjco/hyq095",
language = "English",
volume = "40",
pages = "1073--1080",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "11",

}

Significance of serum concentrations of E-selectin and CA19-9 in the prognosis of colorectal cancer. / Sato, Harunobu; Usuda, Nobuteru; Kuroda, Makoto; Hashimoto, Shuji; Maruta, Morito; Maeda, Koutarou.

In: Japanese Journal of Clinical Oncology, Vol. 40, No. 11, hyq095, 01.11.2010, p. 1073-1080.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Significance of serum concentrations of E-selectin and CA19-9 in the prognosis of colorectal cancer

AU - Sato, Harunobu

AU - Usuda, Nobuteru

AU - Kuroda, Makoto

AU - Hashimoto, Shuji

AU - Maruta, Morito

AU - Maeda, Koutarou

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Objective: Interaction of CA19-9 with E-selectin is involved in initiation of hematogenous metastases. We investigated whether serum concentrations of E-selectin and CA19-9 are good predictors of hematogenous metastases and prognosis in colorectal cancer. Methods: Pre-operative serum samples were obtained from 152 patients with colorectal cancer, and from 28 healthy volunteers. Correlation between serum E-selectin and CA19-9 was studied in terms of clinically detected hematogenous metastases and prognosis of patients. Results: Low serum concentration of E-selectin was defined as <50 U/ml in healthy volunteers, and on that basis, 20.4% of all patients belonged to the high E-selectin group. Several distinctive characteristics were observed in the clinical course of patients with high serum concentrations of both CA19-9 and E-selectin. The rate of Dukes' D cancer was significantly higher, and curative surgery was performed less frequently in patients with high serum concentrations of both CA19-9 and E-selectin (60 and 40%) than in others. However, there was no significant difference in the frequency of recurrence after curative surgery between patients with high serum concentrations of both CA19-9 and E-selectin (25.0%) and others. Overall the 5-year survival rate was significantly lower in patients with high serum concentrations of both CA19-9 and E-selectin (34.3%) than in other patients. Even if the serum concentration of CA19-9 was high, prognosis was not poor in patients with low serum concentration of E-selectin. Conclusions: These results suggested that it was useful to measure both CA19-9 and E-selectin as markers of hematogenous metastases and as predictors of prognosis in colorectal cancer.

AB - Objective: Interaction of CA19-9 with E-selectin is involved in initiation of hematogenous metastases. We investigated whether serum concentrations of E-selectin and CA19-9 are good predictors of hematogenous metastases and prognosis in colorectal cancer. Methods: Pre-operative serum samples were obtained from 152 patients with colorectal cancer, and from 28 healthy volunteers. Correlation between serum E-selectin and CA19-9 was studied in terms of clinically detected hematogenous metastases and prognosis of patients. Results: Low serum concentration of E-selectin was defined as <50 U/ml in healthy volunteers, and on that basis, 20.4% of all patients belonged to the high E-selectin group. Several distinctive characteristics were observed in the clinical course of patients with high serum concentrations of both CA19-9 and E-selectin. The rate of Dukes' D cancer was significantly higher, and curative surgery was performed less frequently in patients with high serum concentrations of both CA19-9 and E-selectin (60 and 40%) than in others. However, there was no significant difference in the frequency of recurrence after curative surgery between patients with high serum concentrations of both CA19-9 and E-selectin (25.0%) and others. Overall the 5-year survival rate was significantly lower in patients with high serum concentrations of both CA19-9 and E-selectin (34.3%) than in other patients. Even if the serum concentration of CA19-9 was high, prognosis was not poor in patients with low serum concentration of E-selectin. Conclusions: These results suggested that it was useful to measure both CA19-9 and E-selectin as markers of hematogenous metastases and as predictors of prognosis in colorectal cancer.

UR - http://www.scopus.com/inward/record.url?scp=78049440004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049440004&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyq095

DO - 10.1093/jjco/hyq095

M3 - Article

C2 - 20576794

AN - SCOPUS:78049440004

VL - 40

SP - 1073

EP - 1080

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 11

M1 - hyq095

ER -